These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30611600)

  • 1. Calcimimetics and Bundled Reimbursement.
    Lin E; Watnick S
    Am J Kidney Dis; 2019 Mar; 73(3):385-390. PubMed ID: 30611600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcimimetic Use in Dialysis-Dependent Medicare Fee-for-Service Beneficiaries and Implications for Bundled Payment.
    Gooding M; Desai P; Owens H; Petrilla AA; Kambhampati M; Levine Z; Young J; Fagan J; Rubin R
    Kidney360; 2020 Oct; 1(10):1091-1098. PubMed ID: 35368776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
    Park H; Rascati KL; Keith MS
    J Manag Care Spec Pharm; 2015 Jun; 21(6):507-14. PubMed ID: 26011552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The initial impact of Medicare's new prospective payment system for kidney dialysis.
    Hirth RA; Turenne MN; Wheeler JR; Nahra TA; Sleeman KK; Zhang W; Messana JA
    Am J Kidney Dis; 2013 Oct; 62(4):662-9. PubMed ID: 23769138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orals in the bundle: a policy framework.
    Feldman RL; Desmarais MP; Muller JS
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):1043-7. PubMed ID: 23599409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
    Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
    Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).
    Brunelli SM; Monda KL; Burkart JM; Gitlin M; Neumann PJ; Park GS; Symonian-Silver M; Yue S; Bradbury BD; Rubin RJ
    Am J Kidney Dis; 2013 Jun; 61(6):947-56. PubMed ID: 23332991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
    Danese MD; Lubeck D; Belozeroff V; Lin TC; Desai P; Gleeson M; Martin K; Chonchol M
    Am J Nephrol; 2020; 51(10):815-822. PubMed ID: 32966995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
    Yusuf AA; Howell BL; Powers CA; St Peter WL
    Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism.
    Gupta C; Chertow GM; Linthicum MT; Van Nuys K; Belozeroff V; Quarles D; Lakdawalla DN
    Health Serv Res; 2014 Dec; 49(6):1925-43. PubMed ID: 25040130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare programs: changes to the end-stage renal disease prospective payment system transition budget-neutrality adjustment. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Apr; 76(66):18930-4. PubMed ID: 21491804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis.
    Spoendlin J; Schneeweiss S; Tsacogianis T; Paik JM; Fischer MA; Kim SC; Desai RJ
    Am J Kidney Dis; 2018 Aug; 72(2):178-187. PubMed ID: 29891194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can we learn from the U.S. expanded end-stage renal disease bundle?
    Chambers JD; Weiner DE; Bliss SK; Neumann PJ
    Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities.
    Wish D; Johnson D; Wish J
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2195-202. PubMed ID: 25189926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.